However, other tumor-level alterations in HSD3B1 are known to occur, including somatic mutations (5), phosphorylation of the 3βHSD1 protein (27), regulation by cancer-associated fibroblasts (28), and regulation by hypoxia-dependent mechanisms (29, 30), which may contribute to clinical outcomes. Here, HSD3B1 is linked to cancer.